EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Synaptic sabotage: How Tau and α-Synuclein undermine synaptic health

Valerie Uytterhoeven iD, Patrik Verstreken iD, Eliana Nachman iD

Journal of Cell Biology · 03.02.2025 · 224 (2)

DOI: 10.1083/jcb.202409104 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cell Biology, online erschienen am 24.12.2024. Verfasst von Valerie Uytterhoeven und 2 weiteren Autor:innen. Beteiligte Einrichtung: Vlaams Instituut voor Biotechnologie Center for Brain and Disease Research , Leuven, Belgium. Hauptthemen laut MEDLINE: alpha-Synuclein, tau Proteins, Synapses. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 307 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Vlaams Instituut voor Biotechnologie, Fonds Wetenschappelijk Onderzoek, European Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Synaptic dysfunction is one of the earliest cellular defects observed in Alzheimer’s disease (AD) and Parkinson’s disease (PD), occurring before widespread protein aggregation, neuronal loss, and cognitive decline. While the field has focused on the aggregation of Tau and α-Synuclein (α-Syn), emerging evidence suggests that these proteins may drive presynaptic pathology even before their aggregation. Therefore, understanding the mechanisms by which Tau and α-Syn affect presynaptic terminals offers an opportunity for developing innovative therapeutics aimed at preserving synapses and potentially halting neurodegeneration. This review focuses on the molecular defects that converge on presynaptic dysfunction caused by Tau and α-Syn. Both proteins have physiological roles in synapses. However, during disease, they acquire abnormal functions due to aberrant interactions and mislocalization. We provide an overview of current research on different essential presynaptic pathways influenced by Tau and α-Syn. Finally, we highlight promising therapeutic targets aimed at maintaining synaptic function in both tauopathies and synucleinopathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-Synucleintau ProteinsSynapsesHumansAnimalsParkinson DiseaseAlzheimer DiseaseSynucleinopathiesTauopathiesPresynaptic Terminals

Substanzen

alpha-Synucleintau Proteins

Autor:innen und Institutionen

  • Vlaams Instituut voor Biotechnologie Center for Brain and Disease Research , Leuven, Belgium.
  • Department of Neurosciences, Leuven Brain Institute, KU Leuven, Leuven, Belgium.

ORCID-Profile: Valerie Uytterhoeven, Patrik Verstreken, Eliana Nachman

Förderung

  • Vlaams Instituut voor Biotechnologie
  • Fonds Wetenschappelijk Onderzoek
  • European Research Council
  • Chan Zuckerberg Initiative
  • Flemish Government
  • Aligning Science Across Parkinson's
  • KU Leuven
  • SAO-FRA

Zitieren

APA

Uytterhoeven, V., Verstreken, P., & Nachman, E. (2025). Synaptic sabotage: How Tau and α-Synuclein undermine synaptic health. Journal of Cell Biology, 224(2). https://doi.org/10.1083/jcb.202409104

Vancouver

Uytterhoeven V, Verstreken P, Nachman E. Synaptic sabotage: How Tau and α-Synuclein undermine synaptic health. Journal of Cell Biology. 2025;224(2). doi:10.1083/jcb.202409104

BibTeX
@article{Uytterhoeven2025,
  author = {Uytterhoeven, Valerie and Verstreken, Patrik and Nachman, Eliana},
  title = {Synaptic sabotage: How Tau and α-Synuclein undermine synaptic health},
  journal = {Journal of Cell Biology},
  year = {2025},
  volume = {224},
  number = {2},
  doi = {10.1083/jcb.202409104}
}
Kostenlos starten →